BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23149615)

  • 1. Glucose transporter 1 (GLUT1) and its emerging role as a significant prognostic marker in systemic malignancies.
    Kapoor S
    Int J Colorectal Dis; 2013 Sep; 28(9):1317-8. PubMed ID: 23149615
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer.
    Shim BY; Jung JH; Lee KM; Kim HJ; Hong SH; Kim SH; Sun DS; Cho HM
    Int J Colorectal Dis; 2013 Mar; 28(3):375-83. PubMed ID: 22847606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of glucose transporter-1 (GLUT1) gene expression in rectal cancer after preoperative chemoradiotherapy.
    Saigusa S; Toiyama Y; Tanaka K; Okugawa Y; Fujikawa H; Matsushita K; Uchida K; Inoue Y; Kusunoki M
    Surg Today; 2012 May; 42(5):460-9. PubMed ID: 22072148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of liver-based standardized uptake value and other quantitative 18F-FDG PET-CT parameters in neoadjuvant therapy response in patients with locally advanced rectal cancer: correlation with histopathology.
    Koç M; Kaya GÇ; Demir Y; Sürücü E; Sarioğlu S; Obuz F; Öztop İ; Görken İB; Sökmen S
    Nucl Med Commun; 2015 Sep; 36(9):898-907. PubMed ID: 25969176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiles of tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Matsushita K; Kawamura M; Okugawa Y; Hiro J; Inoue Y; Uchida K; Mohri Y; Kusunoki M
    Oncol Rep; 2012 Sep; 28(3):855-61. PubMed ID: 22711167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of tumor response after preoperative chemoradiotherapy for rectal adenocarcinomas.
    Guedj N; Bretagnol F; Rautou PE; Deschamps L; Cazals-Hatem D; Bedossa P; Panis Y; Couvelard A
    Hum Pathol; 2011 Nov; 42(11):1702-9. PubMed ID: 21531003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment HIF-1α and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer.
    Havelund BM; Sørensen FB; Lindebjerg J; Spindler KL; Jakobsen A
    Anticancer Res; 2011 May; 31(5):1559-65. PubMed ID: 21617210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two Cases of Pathological Complete Response with Neoadjuvant Therapy for Advanced Rectal Cancer].
    Matsuda C; Danno K; Miyazaki S; Fujitani K; Kubota M; Motoori M; Nakatsuka R; Okumura Y; Nomura M; Nishimura M; Kitagawa A; Matsuura N; Fushimi H; Iwase K
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2313-5. PubMed ID: 26805348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic response grade after long-course neoadjuvant chemoradiation does not influence morbidity in locally advanced mid-low rectal cancer resected by laparoscopy.
    Landi F; Espín E; Rodrigues V; Vallribera F; Martinez A; Charpy C; Brunetti F; Azoulay D; de'Angelis N
    Int J Colorectal Dis; 2017 Feb; 32(2):255-264. PubMed ID: 27757541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of initial FDG-PET/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Lee SJ; Kim JG; Lee SW; Chae YS; Kang BW; Lee YJ; Park JS; Choi GS
    Cancer Chemother Pharmacol; 2013 May; 71(5):1201-7. PubMed ID: 23420438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluation.
    Ruby JA; Leibold T; Akhurst TJ; Shia J; Saltz LB; Mazumdar M; Riedel ER; Larson SM; Guillem JG
    Dis Colon Rectum; 2012 Apr; 55(4):378-86. PubMed ID: 22426260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-related proteins in patients with rectal cancer undergoing neoadjuvant combined modality therapy.
    Lee-Kong SA; Ruby JA; Chessin DB; Pucciarelli S; Shia J; Riedel ER; Nitti D; Guillem JG
    Dis Colon Rectum; 2012 Sep; 55(9):990-5. PubMed ID: 22874607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of thromboembolic events in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy.
    Mezi S; Musio D; Orsi E; de Felice F; Verdinelli I; Morano F; Raffetto N; Tombolini V
    Acta Oncol; 2013 Jan; 52(1):187-90. PubMed ID: 22671575
    [No Abstract]   [Full Text] [Related]  

  • 14. Early rectal cancer: opening the door to change.
    Glynne-Jones R
    Lancet Oncol; 2015 Nov; 16(15):1449-1451. PubMed ID: 26474516
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical outcome of neoadjuvant chemoradiation in locally advanced rectal cancer at a tertiary hospital.
    Yeung WW; Ma BB; Lee JF; Ng SS; Cheung MH; Ho WM; Tsang MW; Chu S; Lam DC; Mo FK
    Hong Kong Med J; 2016 Dec; 22(6):546-55. PubMed ID: 27795447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLUT-1 expression and response to chemoradiotherapy in rectal cancer.
    Brophy S; Sheehan KM; McNamara DA; Deasy J; Bouchier-Hayes DJ; Kay EW
    Int J Cancer; 2009 Dec; 125(12):2778-82. PubMed ID: 19569052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
    Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of clinical predictive factors of pathologic complete response after neoadjuvant chemoradiotherapy in rectal cancer].
    Yu T; Cao XL; Wu GJ; Zhao G; Jia WW; Xiao G; Wang X
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(16):1274-7. PubMed ID: 27122460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant treatment for rectal cancer-A value-based proposition.
    Massarweh NN; Artinyan A; Chang GJ
    J Surg Oncol; 2016 Sep; 114(3):304-10. PubMed ID: 27111410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.